Ventilator-associated pneumonias have been estimated to be the second most common nosocomial infections among children treated in intensive care units. They occur in mechanically ventilated patients through intubation tube or tracheostomy, the infl ammation usually involving the lung parenchyma. The ventilator-associated pneumonia is associated with a longer antibiotic treatment, greater duration of mechanical ventilation (MV) and higher mortality rates in children. The condition is also associated with a higher cost of the treatment. This paper reviews and comments in detail the criteria formulated by the National Nosocomial Infection Surveillance (NNSI) and the Centers for Disease Control and Prevention (CDC) for diagnosis of ventilator-associated pneumonias in children. The disease etiology is associated with the typical causes of nosocomial infections in this age: P. aeruginosa, E. coli and K. pneumoniae. The pathogenesis of the condition is inadequately studied but the aspiration of gastric contents and immune defi ciency are proven risk factors. Two mechanisms have a major role in the development of the disease -micro-aspiration of gastric contents and colonization of the lower airways with pathogens.
INTRODUCTION
Ventilator-associated pneumonia (VAP) is defi ned as a nosocomial infection in which the infl ammatory process involves the lung parenchyma. It occurs in patients on mechanical ventilation using intubation tube or tracheostomy 48 hours or more after initiation of ventilation. This review's goal is to acquaint pediatricians and neonatologists with ventilator-associated pneumonias, the diagnostic criteria and the most common causes of the disease. The authors are not aware of publications on the problem in Bulgarian medical literature. This subject has been insuffi ciently treated in the pediatric intensive care guides published over the past several years. It is unclear what incidence the condition has for pediatric populations as a whole and specifi cally for different ages of children. There is no information on the most common resistant types and their antibiotic sensitivity. VAP mortality rate in childhood in Bulgaria is actually unknown.
Garner et al. and Becerra et al. fi nd that VAP is the second most common nosocomial infections among children treated in intensive pediatric and neonatal units. 2, 3 Asembergiene et al. report that VAP is the most common nosocomial infections in Lithuania. 4 The disease is associated with longer mechanical ventilation, greater length of stay in hospital and in intensive care units, higher mortality rate and higher costs for treatment per patient. It has been found in several major prospective studies that VAP accounts for 6.8 to 32.3% of the nosocomial infections in neonatal intensive care units. The incidence of VAP in newborns correlates to a large extent with the weight at birth and the type of hospital. For mechanically ventilated children in pediatric intensive care units (PICU) the incidence is 3-10% and is higher than that in adults by 15-30%. [5] [6] [7] [8] [9] [10] 
DIAGNOSTIC CRITERIA
The gold standard in diagnosing the pneumonia in adults is the histopathological study of the lungs. However, results vary greatly depending on the pathologist's expertise. There are also signifi cant differences in the bacterial density of the material taken from the respiratory tract or in the histological samples. 11, 12 The revised criteria for diagnosis and defi nitions proposed in 2002 by the National Nosocomial Infection Surveillance (NNSI) and the Centers for Disease Control and Prevention (CDC) are most widely used for the purposes of clinical practice. But they suggest no criteria for the diagnosis of VAP in newborns with low and very low birth weight. Furthermore, these patients present with considerable co-morbidity (hyaline membrane disease, bronchopulmonary dysplasia, neonatal sepsis and necrotizing enterocolitis) which makes it rather diffi cult to fi nd any clinical, laboratory, microbiological and imaging evidence of VAP. 13, 14 There are alternative quantitative criteria used to diagnose VAP, like the clinical pulmonary infection score (CPIS). It assess different clinical parameters by assigning 0 to 2 points to each. A total score > 6 indicates a high probability of VAP. 15 These criteria are not adapted for children though.
The proposed diagnostic criteria for VAP should be used by all centers administering mechanical lung ventilation for infants and children. Ideally, they should be applicable all over the world. Thus researchers and practitioners in the fi eld of intensive medicine will be provided with uniform criteria, and the results will be consistent throughout. 16 Table 1 summarises the clinical criteria on which a diagnosis of VAP is based, as proposed by NNSI and CDC. 13, 17 The clinical signifi cance of each of them is different and will be dealt with therefore separately.
ABNORMAL CHEST RADIOGRAPH For children with underlying bronchopulmonary dysplasia, respiratory distress syndrome, pulmonary edema or chronic obstructive pulmonary disease the diagnosis may be made having only one defi nitive abnormal chest radiograph. 13 In these cases daily routine chest radiographs carry a potential risk for the patient and are therefore justifi ed neither clinically nor economically. 18 The radiographic evidence can be hard to interpret because: • There are diffi culties in differentiating the lung parenchyma consolidation from atelectasis, for instance, in artifi cial hypoventilation, and it is only the parenchyma consolidation that correlates highly with infection.
• Radiographs made at different exposure are diffi cult to compare which hinders the proper assessment of any dynamics.
• There are no changes indicative of VAP.
• There is a decrease of the infi ltrate density on radiographs because of increased X-ray transparency of the surrounding parenchyma in patient ventilation with high positive end-expiratory pressure (PEEP).
• Heart failure and fl uid retention in the lung in patients with sepsis and/or renal failure. There is still no consensus regarding the frequency of radiographic studies in mechanically ventilated patients. It is thought that there should be some limitations (radiographs should be made only if VAP is suspected) because this might reduce the radiation exposure of the patients and the necessary cost of the studies. 15 FEVER Temperature in excess of 38.4 ºC may not be measured in all cases of VAP due to routine use of antipyretics in intensive care units. The different sites for measuring temperature are an added obstacle to developing uniform standards and to data comparison. Measuring rectal temperature is to be preferred over other ways of taking temperature as the external infl uences are minimal. Temperature instability or fever may be accepted as a criterion for VAP only if no heat-producing devices have been used in managing the patient's condition, no regular antipyretic prophylaxis with NSAIDs has been conducted and the patient has been given no wet wraps.
SPUTUM PRODUCTION, BREATHING AND AUSCULTATION
The amount and character of secretion from lower airways (LRA) may vary considerably throughout the day and be infl uenced by many external factors whether or not there is VAP. These include the tolerance of the child to the intubation tube, how much the breathing gas mixture is humidifi ed, the frequency of intubation suctioning and the amount of saline solution used in doing this. Any change in the character of secretion in the tube can be used as a sign of VAP only if the tracheobronchial tree lavage follows identical principles in each unit.
Changes in the respiratory effort (tachypnea, dyspnea or apnea) are clinically signifi cant only in ventilated children who can breathe on their own. In deeply sedated or relaxed children on mechanical ventilation this criterion should not be relied upon.
Any changes in the character of rales should be regarded as an important symptom whose interpretation depends on the experience of the physician, availability of all areas of the lung to study, and the presence of additional obstacles (pneumothorax, pleural effusion, etc.).
INFLAMMATION MARKERS
Leukocytosis or leukopenia have been suggested as criteria for VAP. A shift to the left in the differential blood count is considered an additional criterion in CPIS. But there are cases in which no changes in leukocyte count are registered despite the presence of VAP. Therefore it is rather dubious to use only this indicator to differentiate the presence or absence of bacterial pneumonia. The levels of CRP and procalcitonin may be used as additional infl ammation markers. 19 
CLINICAL AND MICROBIOLOGICAL DIAGNOSIS OF VAP
The clinical criteria used for the VAP diagnosis in adults have a high sensitivity (100%) but very low specifi city (15%). It is therefore quite likely that there can be overdiagnosis of VAP unless the criteria used are critically assessed. 16 No research has been done on the assessment of each of the criteria proposed by the CDC and NNSI for children. The lower airway sampling in children done by bronchoalveolar lavage has been found to have sensitivity of 50 to 72% and specifi city of 80 to 88%. 13 To make a diagnosis of VAP does not require establishment of a causative agent but if highly sensitive clinical criteria can be combined with highly specifi c microbiology sampling the diagnosis can be easier to make. 15 Lower airway sampling for the purpose of isolation of a causative agent in children with VAP has a much greater diagnostic value than the upper airway sampling. 13 Tracheal aspirate (TA) or BALobtained samples can be used in microbiological tests. Aspiration of the trachea is associated with lower risk of physical injury; it does not burden the patient hemodynamics and does not worsen ventilation. Carvalho et al. have found that tracheal aspirates collected serially at 48 hours and 96 hours after intubation increase considerably the likelihood of isolation of an agent compared with single testing. 20 Sampling material obtained by bronchoscopic and non-bronchoscopic lavage (NB-BAL) is more effi cient than tracheal aspirate (TA) as it is taken directly from the alveoli and therefore the possibility of isolating a causative agent is higher. BAL is known to be quite a safe procedure, but the hemodynamic and ventilatory parameters of the child are more likely to be abnormal in conducting it. Sampling by NB-BAL is much easier and more widely applicable than by BAL because no fi ber-bronchoscope and trained staff are needed, and the results themselves are comparable to those obtained by fi broscopic BAL. Quantitative microbiological analysis is also possible where values of the isolated causative agent greater than 10 4 cfu/ml are accepted as signifi cant. 2, 13 
ETIOLOGY
Knowing the structure of the most common causes of VAP is important for taking a valid decision when choosing an antibiotic for the empiric antibiotic therapy. Table 2 presents some of the most common organisms causing VAP in children.
PATHOGENESIS
By time of onset VAP is categorised into an earlyonset VAP (between 48 and 96 hours after initiation of mechanical ventilation) and late-onset VAP (pneumonia occurring after 96 hours of ventilation). The early-onset VAP is usually caused by antibioticsensitive organisms. In contrast, the late-onset VAP is often the consequence of infection with multi-drug resistant bacteria.
A child has several protective mechanisms to prevent bacteria from entering the LRA. These include the anatomical barriers (epiglottis and larynx), the cough refl ex, tracheobronchial secretion, mucociliary clearance, and other secretory substances (lysozyme, complement fractions, defensins, etc.). Immune protective mechanisms include cellular immunity elements (neutrophils, mononuclear cells, eosinophils and macrophages) and humoral immunity elements (secretory IgA). The act of intubation compromises the anatomical barriers protecting LRA, and sedation, muscle relaxation of the patient and mucosal trauma suppress the cough refl ex and the mucociliary clearance.
Pneumonia develops as a result of proliferation of pathogens in the mucosa of the initially sterile LRA and in lung parenchyma. The pathogenesis of VAP includes two major points -the colonization of the respiratory and digestive systems, and microaspiration of infected secretions. There are multiple risk factors ( Table 3 ) that act to potentiate one of these two pathogenetic mechanism. 13, 22 Colonization of the tracheobronchial tree is defi ned as the adherence of bacteria to its mucosal surface in the absence of an infl ammatory response Table 2 . The most common causes of VAP in children
Source
Time of occurrence Causative agent % Asembergiene et al. 4 Not defi ned H. infl uenzae S. aureus by the patient. Bacteria may come from different sources: the oropharynx, the sinuses, dental plaque, the gastrointestinal tract, the breathing circuit, the gas mixture humidifying agents and contaminated tools in manual ventilation. Bacteria from each of the above sources may be inhaled and may enter the LRA. The presence of the endotracheal tube provides a different path for bacterial invasion of lung parenchyma. The secretions from the URT and that from the trachea accumulate and form a Europe and the second most frequent in the U.S. in children treated in the intensive pediatric units. Although the proposed NNSI and CDC criteria for diagnosis of the disease allow for errors in their interpretation, they remain to this moment the only ones that are suitable for widespread clinical use in children. The alternative criteria like CPIS need to be adapted to the pediatric population. Therefore we recommend the diagnostic algorithm suggested by NNSI and CDC. The epidemiology, fi lm around the pipe and its cuff. Just 12 hours after intubation this fi lm already contains a large amount of bacteria that can be inhaled to the LRA during the device-generated inspiration. The resulting biofi lm can be ruptured and can subsequently enter the LRA during the bronchial lavage (dropping of saline solution, aspiration of the intubation tube, a change in its depth) or during coughing attack. Aspiration of gastric contents delivers infected secretions directly to the tracheobronchial tree. Massive aspiration episodes are rare and directly damage the lung parenchyma. Episodes of aspiration of small amounts of secretions are more frequent. Microaspirations of gastric contents can happen only a few hours after intubation. This is facilitated by the lower esophageal sphincter hypotony and increased frequency of episodes of gastroesophageal refl ux and duration during insertion of the nasogastric or orogastric tubes. Enteral tube feeding escalates the gastroesophageal refl ux, increases the gastric content volume and decreases its pH, which also benefi ts the bacterial proliferation. Gastric acidity decreases also as a result of prophylaxis of the stress ulcer and the gastric bleeding by putting the patient on antacid medications. 13, 16 CONCLUSIONS VAP is the most common nosocomial infection in the pathogenesis, the most common causes and the costs associated with the disease have not yet been suffi ciently explored. P. aeruginosa, E. coli and K. pneumoniae were identifi ed as the most frequent causes of VAP in the pediatric population surveyed in this research. Larger scale research is needed for the elaboration of the structure of VAP etiology for the pediatric population in Bulgaria.
